Vimarsana
Biggest News Aggregation in the World

Bobby Laughlin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bobby Laughlin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bobby Laughlin Today - Breaking & Trending Today

Philip "Phil" Warner Laughlin, Warren, Ohio Obituary - Vimarsana News

Philip "Phil" Warner Laughlin, Warren, Ohio Obituary

April 8, 2024

Source: wkbn.com
An illegal psychedelic could change how opioid addiction is treated. It's not without risk | Health - Vimarsana News

An illegal psychedelic could change how opioid addiction is treated. It's not without risk | Health

LEXINGTON, Ky. -- Jessica Blackburn didn’t know she was addicted to opioids until her body’s first withdrawal.

An illegal psychedelic could change how KY treats opioid addiction. It's not without risk | World News - Vimarsana News

An illegal psychedelic could change how KY treats opioid addiction. It's not without risk | World News

LEXINGTON, Ky. -- Jessica Blackburn didn’t know she was addicted to opioids until her body’s first withdrawal. It was 2004, and she was 18. For the last year, she’d swallowed

An illegal psychedelic could change how KY treats opioid addiction. It's not without risk - Vimarsana News

An illegal psychedelic could change how KY treats opioid addiction. It's not without risk

Jessica Blackburn said she experienced severe hallucinations during ibogaine therapy. “It was violent, like being choke-slammed by God.” But she credits ibogaine for helping to combat her opioid addiction.

Source: yahoo.com
Opioid commission leader suggests it use at least $42 million to get exotic psychedelic drug approved to treat opioid-use disorder - Vimarsana News

Opioid commission leader suggests it use at least $42 million to get exotic psychedelic drug approved to treat opioid-use disorder

The head of the commission that manages Kentucky’s opioid-settlement money said Wednesday that the panel will “explore the possibility” of committing “no less than $42 million” to developing a treatment